Fund Name | Location |
Agileo Ventures | - |
Agrega Partners | Distrito Nacional, Dominican Republic, Santo Domingo City |
Alliance Healthcare Investment Fund | Arizona, Scottsdale, United States |
Athenian Venture Partners | Florida, Fort Lauderdale, United States |
BTC123 | Beijing, Beijing, China |
Emerging Markets Property Group (EMPG) | Dubai, United Arab Emirates |
Hunan Xingxiang Investment | Changsha, China, Jiangsu |
Impellent Ventures | New York, Rochester, United States |
IQT | - |
Keren Finance | - |
Naples Technology Ventures | Florida, Naples, United States |
Portugal 2020 | Lisboa, Lisbon, Portugal |
RCI Bank and Services | France, Ile-de-France, Paris |
Seae Ventures | Boston, Massachusetts, United States |
Sociedad Regional de Promocion del Principado de Asturias | Llanera, Spain |
Sony Innovation Fund | Chiyoda, Japan |
Strive Capital | California, San Francisco, United States |
Tsinghua Capital | Beijing, China, Haidian |
Web Capital Group | California, Marina Del Rey, United States |
Yozma Group | Israel, Tel Aviv, Tel Aviv District |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
SOS LAB | $16M | 27 Jul 2022 | South Korea, Gyeonggi-do, South Korea | ||
Ire IS | 27 Apr 2022 | Kangwon-do, Gangwon-do, South Korea | |||
SM Lab | $39M | 09 Dec 2021 | Ulsan, Kyongsang-bukto, South Korea | ||
ArtNGuide | $8M | 05 Oct 2021 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
ILIAS Biologics | $20M | 28 Sep 2020 | South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
SOS LAB | $16M | 27 Jul 2022 | South Korea, Gyeonggi-do, South Korea | ||
Ire IS | 27 Apr 2022 | Kangwon-do, Gangwon-do, South Korea | |||
SM Lab | $39M | 09 Dec 2021 | Ulsan, Kyongsang-bukto, South Korea | ||
ArtNGuide | $8M | 05 Oct 2021 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
ILIAS Biologics | $20M | 28 Sep 2020 | South Korea |